Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × aumolertinib × Clear all

Phase

Phase 2 14 Phase 3 4 Phase 1 3 Phase NA 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Metformin 16 Cyclophosphamide 15 Drug Therapy 14 Dexamethasone 14 Cisplatin 13 Cytarabine 11 Gemcitabine 10 Radiotherapy 9 Vincristine 8 Paclitaxel 8 Oxaliplatin 8 Idarubicin 8 Etoposide 8 Docetaxel 8 Carboplatin 8 ulipristal acetate 7 icotinib 7 Sodium Chloride 7 Methotrexate 7 Fluorouracil 7 Dexmedetomidine 7 entecavir 6 Thalidomide 6 Sorafenib 6 Leuprolide 6 Granulocyte Colony-Stimulating Factor 6 Epirubicin 6 Doxorubicin 6 pegylated granulocyte colony-stimulating factor 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Unknown

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡